SARAH GOUGH: Open Payments
NPI 1487089108 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 10 companies in 2025. Trend: 2023 $1,162 · 2024 $847 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $145 |
| Hologic Sales and Service, LLC | 2 | $56 |
| SHIELD THERAPEUTICS INC | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $33 |
| Exeltis, USA Inc. | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $14 |
Products named: APTIMA, ACCRUFER, MYFEMBREE, ABRYSVO, Veozah, JOURNAVX, Lynkuet, ZURZUVAE.
Industry payments across TX — which companies pay providers there.
